In July 2018, GALVmed’s partner  Boehringer Ingelheim launched a new project known as The Last Mile Initiative. The project is designed to address weak distribution channels and help smallholder farmers in Africa increase their knowledge on disease prevention and treatment. While the Last Mile Initiative was initially launched in Kenya, there are plans to expand […]

In a new article posted on his Gates Notes blog, Bill Gates says rearing goats can greatly boost women’s empowerment, especially in rural areas where money earned from sale of goats stays in the women’s hands and gives them more control of their finances. This means that women not only improve their status within the […]

To commemorate the 2019 World Veterinary Day whose theme was the Value of Vaccination, the Veterinary Social Business (VSB) division of Hester Biosciences Limited, a GALVmed partner in South Asia, recently conducted a weeklong livestock vaccination campaign. The seven-day campaign was an innovative awareness activity on the value of livestock vaccination. The campaign targeted all […]

GALVmed partner Hester Biosciences Limited has launched a campaign to sensitise farmers about animal health and management. The campaign is one of the initiatives to kick start a new programme which aims to provide over two million smallholder farmers with animal health products in the Indian states of Uttar Pradesh and Bihar and in Nepal […]

A field study to explore the practical viability of non-invasive, simultaneous administration of commercial Fowl Pox and Newcastle Disease vaccines could potentially help to control both diseases for smallholder farmers. The study is currently being implemented in Hanang district in Tanzania, by GALVmed and its local partner Open University of Tanzania. The objective of the […]

Some projects funded under the just concluded phase of Protecting Livestock II are already showing promising signs of sustainability. The projects that were implemented with Hester Biosciences in India were aimed at distributing a new thermo-tolerant Newcastle disease vaccine to smallholder farmers. The vaccine manufactured by Hester was being distributed in smaller 100 dose packs. […]

GALVmed Chief Executive, Peter Jeffries, gives an insight into how GALVmed and its partners work to achieve its goal of making livestock vaccines, diagnostics and medicines accessible and affordable to millions of smallholder farmers.

GALVmed recently convened a meeting of key East Coast fever disease stakeholders in Uganda to discuss the final report of the ECF field safety and efficacy study. The meeting took place at the Lake Victoria Hotel in Entebbe Uganda on Friday 23rd February 2018. In attendance representing GALVmed were Dr Jeremy Salt, Chief Scientific Officer […]

Part 2: GALVmed CEO Peter Jeffries gives an update on the Brucellosis vaccine prize competition.

Part 1: GALVmed CEO Peter Jeffries gives an update on the Brucellosis vaccine prize competition.